C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2009
12/15/2009	US7632681 Compositions and methods for propagation of neural progenitor cells
12/15/2009	US7632680 Differentiating the obtained central nervous system (CNS) stem cells by culturing stems cells in vitro in differentiation medium containing fibroblast growth factor 8 and glial cell line derived neurotrophic factor, transplanting them into CNS
12/15/2009	US7632679 Systems and methods for screening for modulators of neural differentiation
12/15/2009	US7632678 neuroblastoma tumor-initiating cells derived from a bone marrow aspirate or a tumor sample taken from the body of an individual having neuroblastoma disease; used for screening a sample to identify the stage of neuroblastoma present; drug screening anticarcinogenic agent for treating neuroblastoma
12/15/2009	US7632677 Cell line expressing mutated human tissue-type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein
12/15/2009	US7632676 Plant virus vector
12/15/2009	US7632669 Lipolytic enzyme variants
12/15/2009	US7632667 Mutan endonuclease with substrate-specific cleavage activity
12/15/2009	US7632661 Expression elements
12/15/2009	US7632643 PCA3, PCA3 genes, and methods of use
12/15/2009	US7632516 Moraxella catarrhalis BASB115 polypeptides
12/15/2009	US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
12/15/2009	US7632504 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability
12/15/2009	US7632501 Antibodies against monocyte chemotactic proteins
12/15/2009	US7632500 Immunoglobulin for use in prevention and treatment inflammatory disease
12/15/2009	US7632498 MCM6 and MCM7 monoclonal antibodies and methods for their use in the detection of cervical disease
12/15/2009	CA2411968C Protein glycosylation modification in pichia pastoris
12/15/2009	CA2315885C .alpha.1, 4-galactosyltransferase and dna encoding thereof
12/15/2009	CA2308604C Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use
12/15/2009	CA2294996C Angiotensin derivatives
12/15/2009	CA2291803C Methods for coexpression of more than one gene using at least one internal ribosome entry site (ires)
12/15/2009	CA2269096C Method for in vitro preconditioning of myoblasts before transplantation
12/15/2009	CA2243088C Humanized green fluorescent protein genes and methods
12/15/2009	CA2209315C Gibberellins compounds for veterinary and medicinal applications
12/10/2009	WO2009149307A2 Compositions and methods for restoring mitochondrial electron transfer function
12/10/2009	WO2009149233A1 Methods for the production of ips cells using non-viral approach
12/10/2009	WO2009149189A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009	WO2009149185A2 Dual variable domain immunoglobulins and uses thereof
12/10/2009	WO2009149176A1 6-substituted estradiol derivatives and methods of use
12/10/2009	WO2009148896A2 Anti-phospho-akt antibodies
12/10/2009	WO2009148622A1 Compositions and methods for growing embryonic stem cells
12/10/2009	WO2009148575A1 Interleukin-1 alpha abs and methods of use
12/10/2009	WO2009148568A1 Human facilitating cells
12/10/2009	WO2009148194A1 Polynucleotide for releasing recombinant protein to the outside of eukaryotic cell
12/10/2009	WO2009148177A1 Method for evaluation of developmental toxicity
12/10/2009	WO2009148170A1 Method for culture of stem cell
12/10/2009	WO2009148057A1 Reprogramming of blood cells
12/10/2009	WO2009147984A1 Dna encoding polypeptide involved in biosynthesis of herboxidiene
12/10/2009	WO2009147455A2 Method of differentiated development of genetic cells in a substratum autologous - heterologous targeted fixation cryopreservation bank of regenerated fluid tissues - tissues
12/10/2009	WO2009147445A1 Pluripotency associated epigenetic factor
12/10/2009	WO2009147400A1 Stem cell culture media and methods
12/10/2009	WO2009147209A2 Method for and material of a shape standard
12/10/2009	WO2009146887A2 Novel treatment of heart diseases
12/10/2009	WO2009146746A1 Use of fxa, fviia, tf, or a combination thereof as anti-apoptotic agents
12/10/2009	WO2009111644A3 Compositions and methods for diagnosing and treating pancreatic cancer
12/10/2009	WO2009108777A3 Use of nitrite to enhance viability, recovery, and function of transplant specimens
12/10/2009	WO2009102983A3 Efficient induction of pluripotent stem cells using small molecule compounds
12/10/2009	WO2008111064A9 Vascularized islets and methods of producing same
12/10/2009	US20090307805 Alternative nucleotides for improved targeted nucleotide exchange
12/10/2009	US20090307801 Novel plants
12/10/2009	US20090307800 Compositions and Methods of Use of Mitogen-Activated Protein Kinase Kinase Kinase
12/10/2009	US20090307798 Polynucleotides and Methods for Making Plants Resistant to Fungal Pathogens
12/10/2009	US20090307796 Plants with increased tolerance to water deficit
12/10/2009	US20090307795 Zmtcrr-1 plant signal transduction gene and promoter
12/10/2009	US20090307794 Stress-Induced Transcription Factor Derived from Maize
12/10/2009	US20090307791 Calcium-activated chloride channel and methods of use thereof
12/10/2009	US20090307790 Isolation of the t-complex distorters and applications thereof
12/10/2009	US20090307789 Transgenic mollusk and method for producing the same
12/10/2009	US20090307788 Ribozyme mediated stabilization of polynucleotides
12/10/2009	US20090307785 Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
12/10/2009	US20090306790 Elastase Treatment of Tissue Matrices
12/10/2009	US20090306775 Artificial ligaments and tendons comprising multifilaments and nanofibers and methods for making
12/10/2009	US20090306193 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
12/10/2009	US20090306192 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
12/10/2009	US20090306188 Importation of mitochondrial protein by an enhanced allotopic approach
12/10/2009	US20090306181 Compositions and methods for evaluating and treating heart failure
12/10/2009	US20090306180 Compounds and methods for modulating expression apob
12/10/2009	US20090306179 Compounds and methods for modulating expression of gcgr
12/10/2009	US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
12/10/2009	US20090306131 Cell lines with latent immunodeficiency virus and methods of use thereof
12/10/2009	US20090306125 Mitochondria-Targeted Antioxidant Prodrugs and Methods of Use
12/10/2009	US20090306112 Antiviral protease inhibitors
12/10/2009	US20090306005 Compounds and methods for modulating expression of pcsk9
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305987 Method For Inducing Beta Cell Neogenesis From Epithelial Cells
12/10/2009	US20090305986 FGF21 Mutants and uses thereof
12/10/2009	US20090305985 Immunomodulatory Agents For Treatment of Inflammatory Diseases
12/10/2009	US20090305982 Muteins of tear lipocalin and methods for obtaining the same
12/10/2009	US20090305981 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers
12/10/2009	US20090305980 Methods and Compositions Related to TR4
12/10/2009	US20090305972 Novel cancer-associated antigen
12/10/2009	US20090305971 Nogo-B Receptor
12/10/2009	US20090305969 Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active Ingredient
12/10/2009	US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
12/10/2009	US20090305961 Novel chimeric plasminogen activators and their pharmaceutical use
12/10/2009	US20090305954 Histidine-containing diastereomeric peptides and uses thereof
12/10/2009	US20090305950 Multimer of extracellular domain of cell surface functional molecule
12/10/2009	US20090305946 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta )
12/10/2009	US20090305900 Genemap of the human genes associated with longevity
12/10/2009	US20090305419 Compositions for linking DNA-binding domains and cleavage domains
12/10/2009	US20090305418 Cell therapy method for the treatment of tumors
12/10/2009	US20090305417 Cell culture
12/10/2009	US20090305416 Method for regulating proliferation of cells
12/10/2009	US20090305415 Method for preserving proliferation and differentiation potential of undifferentiated cells
12/10/2009	US20090305414 Methods Of Tissue Engineering
12/10/2009	US20090305413 Multipotent adult stem cells having an ability of oct4 expression derived from umbilical cord blood and method for preparing the same
12/10/2009	US20090305412 Mechanically reversible gel
12/10/2009	US20090305411 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors
12/10/2009	US20090305410 Fluorescent compounds
12/10/2009	US20090305409 Liposome Capable of Effective Delivery of Given Substance Into Nucleus

1 ... 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 ... 1827